These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21272804)

  • 1. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E; Hanauer SB
    J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
    Tuyama AC; Krakauer M; Alzaabi M; Fiel MI; Legnani P; Schiano TD
    J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z
    Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease].
    Laish I; Pomeranz I; Kitay-Cohen Y; Konikof F
    Harefuah; 2012 Dec; 151(12):692-5, 720. PubMed ID: 23330262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L; Marko C; Breidert M
    Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
    Musumba CO
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1025-37. PubMed ID: 24099468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurines in Crohn's disease, is there something new?
    Miheller P; Lakatos PL
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and response to thiopurines in patients with inflammatory bowel disease.
    Goldberg R; Irving PM
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):891-900. PubMed ID: 25915575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL; Miles CJ; Gearry RB
    N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
    Seiderer J; Zech CJ; Diebold J; Schoenberg SO; Brand S; Tillack C; Göke B; Ochsenkühn T
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
    Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia.
    De Boer NK; Tuynman H; Bloemena E; Westerga J; Van Der Peet DL; Mulder CJ; Cuesta MA; Meuwissen SG; Van Nieuwkerk CM; Van Bodegraven AA
    Scand J Gastroenterol; 2008; 43(5):604-8. PubMed ID: 18415755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 15. A histopathologic pattern of centrilobular hepatocyte injury suggests 6-mercaptopurine-induced hepatotoxicity in patients with inflammatory bowel disease.
    Masia R; Pratt DS; Misdraji J
    Arch Pathol Lab Med; 2012 Jun; 136(6):618-22. PubMed ID: 22646267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W; Marlicz W; Smereczyński A; Lawniczak M; Lewosiuk A; Starzyńska T
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C; Chaparro M; Espinosa L; Bejerano A; Maté J; Gisbert JP
    Gastroenterol Hepatol; 2011; 34(6):385-92. PubMed ID: 21616565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D; Decaestecker J; De Wulf D; Ghillebert G; Van Vlierberghe H; Van Dorpe J; Baert F
    Acta Gastroenterol Belg; 2013 Sep; 76(3):342-6. PubMed ID: 24261031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease?
    Ledder OD; Lemberg DA; Ooi CY; Day AS
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):583-6. PubMed ID: 23783022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.